We have shown in this work that administration of Nano-PSO, a Nano-formulation of PSO previously shown to delay disease progression in a genetic model of CJD as well as in EAE40, resulted in incorporation of substantial levels of CLA into the brains of treated mice. Here, SELPLG is linked to Creutzfeldt Jacob disease.